Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Alsughayer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Breast Cancer (Tokyo, Japan)|April 26, 2018
Applying new Magee equations for predicting the Oncotype Dx recurrence scoreMaher Sughayer, Rolla Alaaraj, Ahmad Alsughayer
Cytojournal|December 29, 2025
Interobserver concordance of tumor-infiltrating lymphocyte assessment in triple-negative breast carcinoma; tissue microarray versus whole sectionsMaher Sughayer, Fareed Barakat, Elizabeth Sweidan, et al.
Technology in Cancer Research & Treatment|November 13, 2025
Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Colorectal Cancer and Its Clinical Significance among Jordanian PatientsZaid Atieh, Maher Obeidat, Ahmad Alsughayer, et al.
World Journal of Oncology|November 10, 2025
A Simplified Novel Algorithm to Predict the 21-Gene Recurrence ScoreMaher A Sughayer, Bayan Maraqa, Batool Qura'an, et al.
Inflammatory Bowel Diseases|January 23, 2019
Short- and Long-term Outcomes After Ileal Pouch Anal Anastomosis in Pediatric Patients: A Systematic ReviewAmy L Lightner, Ahmad Alsughayer, Zhen Wang, et al.
Diseases of the Colon and Rectum|November 20, 2020
Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched AnalysisAhmad Alsughayer, Fabian Grass, Nicholas P McKenna, et al.
Journal of Pediatric Surgery|February 19, 2019
Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patientsAmy L Lightner, Nicholas P McKenna, Ahmad Alsughayer, et al.
Inflammatory Bowel Diseases|May 4, 2019
Development of an Objective Model to Define Near-Term Risk of Ileocecal Resection in Patients with Terminal Ileal Crohn DiseaseFabian Grass, Joel G Fletcher, Ahmad Alsughayer, et al.
Diseases of the Colon and Rectum|October 1, 2019
Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?Amy L Lightner, Nicholas P McKenna, Ahmad Alsughayer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Breast Cancer (Tokyo, Japan)|April 26, 2018
Applying new Magee equations for predicting the Oncotype Dx recurrence scoreMaher Sughayer, Rolla Alaaraj, Ahmad Alsughayer
Cytojournal|December 29, 2025
Interobserver concordance of tumor-infiltrating lymphocyte assessment in triple-negative breast carcinoma; tissue microarray versus whole sectionsMaher Sughayer, Fareed Barakat, Elizabeth Sweidan, et al.
Technology in Cancer Research & Treatment|November 13, 2025
Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Colorectal Cancer and Its Clinical Significance among Jordanian PatientsZaid Atieh, Maher Obeidat, Ahmad Alsughayer, et al.
World Journal of Oncology|November 10, 2025
A Simplified Novel Algorithm to Predict the 21-Gene Recurrence ScoreMaher A Sughayer, Bayan Maraqa, Batool Qura'an, et al.
Inflammatory Bowel Diseases|January 23, 2019
Short- and Long-term Outcomes After Ileal Pouch Anal Anastomosis in Pediatric Patients: A Systematic ReviewAmy L Lightner, Ahmad Alsughayer, Zhen Wang, et al.
Diseases of the Colon and Rectum|November 20, 2020
Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched AnalysisAhmad Alsughayer, Fabian Grass, Nicholas P McKenna, et al.
Journal of Pediatric Surgery|February 19, 2019
Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patientsAmy L Lightner, Nicholas P McKenna, Ahmad Alsughayer, et al.
Inflammatory Bowel Diseases|May 4, 2019
Development of an Objective Model to Define Near-Term Risk of Ileocecal Resection in Patients with Terminal Ileal Crohn DiseaseFabian Grass, Joel G Fletcher, Ahmad Alsughayer, et al.
Diseases of the Colon and Rectum|October 1, 2019
Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?Amy L Lightner, Nicholas P McKenna, Ahmad Alsughayer, et al.
Pageof 1